ENTRY       D02499                      Drug
NAME        Enfuvirtide (USAN/INN);
            Fuzeon (TN)
  ABBR      EFV, T-20
PRODUCT     FUZEON (Genentech)
FORMULA     C204H301N51O64
EXACT_MASS  4489.1866
MOL_WEIGHT  4491.876
SEQUENCE    Ac-Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln
            Gln Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser
            Leu Trp Asn Trp Phe-NH2
  TYPE      Peptide
CLASS       Antiviral
             DG03107  Anti-HIV agent
REMARK      ATC code: J05AX07
            Product: D02499<US>
EFFICACY    Antiviral, HIV-1 gp41 fusion inhibitor
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 gp41 [KO:K24801]
  PATHWAY   ko03230(K24801)  Viral genome structure
            ko03250(K24801)  Viral life cycle - HIV-1
INTERACTION  
STR_MAP     map07053  Anti-HIV agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AX Other antivirals
                 J05AX07 Enfuvirtide
                  D02499  Enfuvirtide (USAN/INN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Agents, Other
               Enfuvirtide
                D02499  Enfuvirtide (USAN/INN)
            Drug groups [BR:br08330]
             Antiviral
              DG03107  Anti-HIV agent
               D02499  Enfuvirtide
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D02499  Enfuvirtide
            Antimicrobials [BR:br08307]
             Antivirals
              Entry, fusion or uncoating inhibitor
               HIV gp41/gp120
                D02499  Enfuvirtide (USAN/INN) &lt;US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antivirals
              Entry, fusion or uncoating inhibitor
               HIV gp41/gp120
                D02499  Enfuvirtide (USAN/INN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D02499
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02499
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D02499
DBLINKS     CAS: 159519-65-0
            PubChem: 17396673
            ChEBI: 608828
            NIKKAJI: J2.173.441A
///
